Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready
Rescue Hearing Inc. is involved in the Biotechnology & Pharmaceuticals technology area. The company's patent prosecution data shows 2 pending office actions. Notably, these actions are handled by 1 distinct examiner and are located within 1 distinct art unit. This concentration indicates that despite having multiple active challenges, the company is interacting with a very narrow segment of the USPTO. The focus on 1 distinct art unit suggests a consistent technical theme across the pending applications.
The busiest examiner, NICOL, ALEXANDER W, is currently overseeing 2 busiest examiner pending office actions. Because the total number of pending office actions is 2, this single examiner manages all of the company's current prosecution tasks. For the practitioner, this means that the prosecution strategy is entirely dependent on the feedback and requirements of NICOL, ALEXANDER W. The alignment of 2 pending office actions within 1 distinct art unit simplifies the administrative tracking but centralizes the risk or opportunity with 1 individual. This profile suggests a high degree of examiner influence over the company's biotech assets.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| §112 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NICOL, ALEXANDER W | 2 | 42.7% | +43.6% |
| KONOPKA, CATHERINE ANNE | 1 | 57.5% | +66.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560867 | GENE THERAPY CONSTRUCTS AND METHODS FOR TREATMENT OF HEARING LOSS | KONOPKA, CATHERINE ANNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16726495 | GENE THERAPY CONSTRUCTS AND METHODS FOR TREATMENT OF HEARING LOSS | NICOL, ALEXANDER W | 87d overdue |
| 16488103 | Gene Therapy Constructs and Methods for Treatment of Hearing Loss | NICOL, ALEXANDER W | 87d overdue |
| 18560867 | GENE THERAPY CONSTRUCTS AND METHODS FOR TREATMENT OF HEARING LOSS | KONOPKA, CATHERINE ANNE | — |
| Art Unit | Apps |
|---|---|
| 1634 | 2 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18560867 | GENE THERAPY CONSTRUCTS AND METHODS FOR TREATMENT OF HEARING LOSS | KONOPKA, CATHERINE ANNE | 1635 | §101§103§112DP | Final Rejection | — | Pending | Nov 14, 2023 |
| 16726495 | GENE THERAPY CONSTRUCTS AND METHODS FOR TREATMENT OF HEARING LOSS | NICOL, ALEXANDER W | 1634 | §112 | Final Rejection | 87d overdue | Pending | Dec 24, 2019 |
| 16488103 | Gene Therapy Constructs and Methods for Treatment of Hearing Loss | NICOL, ALEXANDER W | 1634 | §103 | Non-Final OA | 87d overdue | Pending | Aug 22, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRescue Hearing Inc. has 3 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Alexander W Nicol has the most, with 2 of Rescue Hearing Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
